Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
American Journal of Public Health|April 20, 2018
Standard Death Certificates Versus Enhanced Surveillance to Identify Heroin Overdose-Related DeathsIsabelle L Horon, Pooja Singal, David R Fowler, et al.
Health Affairs (Project Hope)|April 3, 2018
Changes In Hospital Utilization Three Years Into Maryland's Global Budget Program For Rural HospitalsEric T Roberts, Laura A Hatfield, J Michael McWilliams, et al.
Science (New York, N.Y.)|August 4, 2022
Transparency practices at the FDA: A barrier to global healthMurray M Lumpkin, Margaret A Hamburg, William B Schultz, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|July 28, 2022
INTRODUCTION Disrupting the Status Quo: Building Equitable Access to HIV PrEP in the US through Innovative FinancingJeremiah Johnson, Amy Killelea, Derek T Dangerfield, et al.
JAMA Internal Medicine|January 18, 2018
Changes in Health Care Use Associated With the Introduction of Hospital Global Budgets in MarylandEric T Roberts, J Michael McWilliams, Laura A Hatfield, et al.
JAMA|January 12, 2026
The US Food and Drug Administration's Regulation of MifepristoneSophie Dilek, Joanne Rosen, Anna Levashkevich, et al.
The Journal of School Health|February 26, 2026
Cracks in the Foundation: The Association of Physical Condition of School Facilities With Absenteeism and Test Scores in MarylandCatherine H Gong, Richard Lofton, Priyanka Fernandes, et al.
The New England Journal of Medicine|November 13, 2015
Maryland's Global Hospital Budgets--Preliminary Results from an All-Payer ModelAnkit Patel, Rahul Rajkumar, John M Colmers, et al.
JAMA Internal Medicine|December 31, 2019
Evaluation of the Extended-Release/Long-Acting Opioid Prescribing Risk Evaluation and Mitigation Strategy Program by the US Food and Drug Administration: A ReviewJames Heyward, Lily Olson, Joshua M Sharfstein, et al.
Pharmacology Research & Perspectives|December 21, 2019
Evaluating the centralized purchasing policy for the treatment of hepatitis C: The Colombian CASEAngela V Pérez, Antonio J Trujillo, Aurelio E Mejia, et al.
Pageof 8